Paper Review Records
All Paper Review Records
14 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
39
days
Vaccination against neoantigens induced in cross-priming cDC1 in vivo
Authors
Emily S. Clark; Ana Paula Benaduce; Wasif N. Khan; Olivier Martinez; Eli GilboaShow moreShow less
Affiliations
1. Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, USA; 2. Department of Biological Sciences, Florida International University, Miami, USA; 3. Mnemo Therapeutics, Paris, France; 4. Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, USAShow moreShow less
45
days
Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastases
Authors
Celine Man Ying Li; Yoko Tomita; Bimala Dhakal; Teresa Tin; Runhao Li; Josephine A. Wright; Laura Vrbanac; Susan L. Woods; Paul Drew; Timothy Price; Eric Smith; Guy J. Maddern; Kevin FenixShow moreShow less
Affiliations
1. Discipline of Surgery, Adelaide Medical School, The University of Adelaide, Adelaide, Australia; 2. The Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Adelaide, Australia; 3. Medical Oncology, The Queen Elizabeth Hospital, The University of Adelaide, Adelaide, Australia; 4. Precision Medicine, South Australian Health and Medical Research Institute, Adelaide, Australia; 5. Department of Medical Specialties, Adelaide Medical School, The University of Adelaide, Adelaide, AustraliaShow moreShow less
46
days
Rescue of NLRC5 expression restores antigen processing machinery in head and neck cancer cells lacking functional STAT1 and p53
Authors
Brendan L. C. Kinney; Sreenivasulu Gunti; Vikash Kansal; Connor J. Parrish; Nabil F. Saba; Yong Teng; Mary Katherine Henry; Fang-Yi Su; Gabriel A. Kwong; Nicole C. SchmittShow moreShow less
Affiliations
1. Department of Otolaryngology – Head and Neck Surgery, Head and Neck Cancer Program, Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA; 2. Winship Cancer Institute, Emory University, Atlanta, USA; 3. National Institute of Deafness and Communication Disorders, NIH, Bethesda, USA; 4. Saint Louis University School of Medicine, St. Louis, USA; 5. Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, USA; 6. Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory School of Medicine, Atlanta, USA; 7. Emory University School of Medicine, Atlanta, USAShow moreShow less
108
days
Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies
Authors
Xinfeng Chen; Binghe Tan; Haizhou Xing; Xuan Zhao; Yu Ping; Zhen Zhang; Jianmin Huang; Xiujuan Shi; Na Zhang; Boxu Lin; Weijie Cao; Xin Li; Xudong Zhang; Ling Li; Zhongxing Jiang; Mingzhi Zhang; Wei Li; Mingyao Liu; Bing Du; Yi ZhangShow moreShow less
Affiliations
1. Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 2. Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 3. Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China; 4. BRL Medicine Inc, Shanghai, China; 5. Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 6. State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou, China; 7. School of Life Sciences, Zhengzhou University, Zhengzhou, China; 8. Engineering Key Laboratory for Cell Therapy of Henan Province, Zhengzhou, ChinaShow moreShow less
132
days
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells
Authors
Libao Liu; Laurie Rangan; Nathan Vanalken; Qianqian Kong; Susan Schlenner; Steven De Jonghe; Dominique Schols; Tom Van LoyShow moreShow less
Affiliations
1. Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium; 2. Laboratory of Adaptive Immunology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, BelgiumShow moreShow less
82
days
Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors
Authors
M Costa-Garcia; JJ Rojas; MD Ramos; P Barlabé; P Calvo; J Navas; R Alemany; R MorenoShow moreShow less
Affiliations
1. Cancer Immunotherapy Group, Oncobell and iProCURE programs, IDIBELL-Institut Català d’Oncologia, l’Hospitalet de Llobregat, Barcelona, Spain; 2. Immunology Unit, Department of Pathology and Experimental Therapies, School of Medicine, University of Barcelona-UB, Barcelona, Spain; 3. Immunity, Inflammation, and Cancer Group, Oncobell program, Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, l’Hospitalet de Llobregat, Barcelona, Spain; 4. Program of Regenerative Medicine, Centre for Applied Medical Research (CIMA), University of Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Pamplona, SpainShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
